ETFdb Logo
ETFdb Logo
  • ETF Database
  • Channels
    • Active ETF
    • Alternatives
    • Beyond Basic Beta
    • China Insights
    • Climate Insights
    • Commodities
    • Core Strategies
    • Crypto
    • Disruptive Technology
    • Dividend
    • Dual Impact
    • Emerging Markets
    • Energy Infrastructure
    • ESG
    • ETF Building Blocks
    • ETF Education
    • ETF Strategist
    • Fixed Income
    • Free Cash Flow
    • Future ETFs
    • Global Diversification
    • Gold & Silver Investing
    • Innovative ETFs
    • Institutional Income Strategies
    • Leveraged & Inverse
    • Managed Futures
    • Market Insights
    • Megatrends
    • Modern Alpha
    • Multi-Asset
    • Night Effect
    • Portfolio Strategies
    • Retirement Income
    • Richard Bernstein Advisors
    • Tax Efficient Income
    • Thematic Investing
    • Volatility Resource
  • Tools
    • ETF Screener
    • ETF Country Exposure Tool
    • ETF Sector Tracker Tool
    • ETF Database Categories
    • Head-To-Head ETF Comparison Tool
    • ETF Stock Exposure Tool
    • ETF Issuer Fund Flows
    • Indexes
    • Mutual Fund To ETF Converter
    • ETF Data for Journalists
    • ETF Nerds
  • Research
    • First Bitcoin ETF
    • ETF Education
    • Equity Investing
    • Dividend ETFs
    • Leveraged ETFs
    • Inverse ETFs
    • Index Education
    • Index Insights
    • Top ETF Sectors
    • Top ETF Issuers
    • Top ETF Industries
  • Webcasts
  • Themes
    • AI ETFs
    • Blockchain ETFs
    • See all Thematic Investing ETF themes
    • ESG Investing
    • Marijuana ETFs
  • Multimedia
    • ETF 360 Video Series
    • ETF Trends on Videos
    • ETF Trends on Podcasts
    • ETF Prime Podcast
  • Company
    • About Us
    • Swag Store
  • PRO
    • Pro Content
    • Pro Tools
    • Advanced
    • FAQ
    • Pricing
    • Free Sign Up
    • Login
  1. Core Strategies Channel
  2. FDA Approves Pfizer’s Vaccine for Kids 5–11
Core Strategies Channel
Share

FDA Approves Pfizer’s Vaccine for Kids 5–11

Karrie GordonOct 29, 2021
2021-10-29

This week, vaccine advisors for the FDA voted affirmatively for an emergency approval for the use of Pfizer’s COVID-19 vaccine in children ages 5–11, a vote of 17-0 with one abstaining, reported CNN.

The vaccine from Pfizer and BioNTech is a third of the dose given to adults and children over 12 and has a 90% efficacy. While the sample size of children was smaller, the members of the FDA Vaccines and Related Biological Products Advisory Committee believe that any risks of side effects are vastly outweighed by the benefits.

A CDC official said that COVID-19 was “the eighth-highest killer of kids in this age group over the past year,” according to the New York Times.

One of the concerns for children is a risk of an inflammatory heart condition called myocarditis, which has cropped up in young men in particular who have received the Pfizer or Moderna vaccine. The sample size was too small to determine if children were also at risk. Experts believe that the smaller dose should help alleviate the chances of that occurring.

Vaccine advisors for the CDC are set to meet on Tuesday and Wednesday of next week to discuss the FDA’s findings and decide whether to recommend this dosage and vaccine for kids within the 5–11 age group, a total of 28 million children. If the CDC Director Rochelle Walensky gives the final thumbs-up, vaccines could begin rolling out as early as next week.

American Century Invests in Pfizer With VALQ

With a rollout to an entire new age group of the Pfizer vaccine on the immediate horizon and boosters continuing to be administered, Pfizer is positioned to continue its growth looking forward.

The American Century STOXX U.S. Quality Value ETF (VALQ B) seeks to track the iSTOXX American Century USA Quality Value Index, a rules-based index that selects large- and mid-cap companies that are perceived to be undervalued or have sustainable income, including companies such as Pfizer.


Content continues below advertisement

American Century STOXX US Quality Val ETF

The underlying index pulls from the STOXX USA 900 Index, which has 900 of the biggest U.S equity securities that are publicly traded and weights securities based on value, quality, and income.

The underlying index is screened for quality with the bottommost stocks removed from consideration; the remaining are calculated to create a valuation score based on earnings yield, value, and cash flow yield metrics compared to peers. Of the dividend-paying securities, the bottommost are also filtered out using an income sustainability screen that accounts for dividend growth as well as dividend coverage metrics, and the remaining securities are assigned an income score based on their dividend yield.

The value stocks and income stocks are combined within the index utilizing their scores to optimize the portfolio. At any given time, the index will typically consist of 200–300 securities.

Pfizer (PFE) is carried at a 2.4% weighting in the fund, along with Alphabet (GOOGL) at 2.08%, and Apple (AAPL) at 1.76%.

VALQ carries an expense ratio of 0.29% and had 243 holdings as of the end of August.

For more news, information, and strategy, visit the Core Strategies Channel.

Loading Articles...
Help & Info
  • Contact Us
Tools
  • ETF Screener
  • ETF Analyzer
  • Mutual Fund to ETF Converter
  • Head-To-Head ETF Comparison
  • ETF Country Exposure Tool
  • ETF Stock Exposure Tool
  • ETF Performance Visualizer
  • ETF Database Model Portfolios
  • ETF Database Realtime Ratings
  • ETF Database Pro
More Tools
  • ETF Launch Center
  • Financial Advisor & RIA Center
  • ETF Database RSS Feed
Explore ETFs
  • ETF News
  • ETF Picks of the Month
  • ETF Category Reports
  • Premium Articles
  • Alphabetical Listing of ETFs
  • Best ETFs
  • Browse ETFs by ETF Database Category
  • Browse ETFs by Index
  • Browse ETFs by Issuer
  • Compare ETFs
Legal
  • Terms of Use and Privacy Policy
  • © 2023 VettaFi LLC. All rights reserved.
Follow ETF Database
Follow ETF Database

Advertisement

Is Your Portfolio Positioned With Enough Global Exposure?

ETF Education Channel

How to Allocate Commodities in Portfolios

Tom LydonApr 26, 2022
2022-04-26

A long-running debate in asset allocation circles is how much of a portfolio an investor should...

Core Strategies Channel

Why ETFs Experience Limit Up/Down Protections

Karrie GordonMay 13, 2022
2022-05-13

In a digital age where information moves in milliseconds and millions of participants can transact...

}
X